The PennZone

  • Home
  • Business
  • Health
  • Education
  • Non-profit
  • Technology
  • Financial
  • Entertainment
  • Marketing

Kessler Topaz Meltzer & Check, LLP Reminds Missfresh Limited Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
The PennZone/10197976

Trending...
  • UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
  • CCHR Florida: Mental Health Awareness Month Open House
  • Introducing LĪNA Universal Balm: A Luxury Multi-Use, Plant-Powered Solution for Skin & Hair
RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Missfresh Limited ("Missfresh") (NASDAQ: MF). The action charges Missfresh with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Missfresh's materially misleading statements and omissions to the public, Missfresh investors have suffered significant losses.

CLICK HERE TO SUBMIT YOUR MISSFRESH LOSSES. YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/new-cases/missfresh-limited?utm_source=PR&utm_medium=link&utm_campaign=missfreshx&mktm=r

TO VIEW OUR VIDEO, PLEASE CLICK HERE

More on The PennZone
  • Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
  • Author Chandra Donelson Visits the Children's Museum of Pittsburgh
  • Chandra Donelson Headlines the Hike2 Innovation Summit 2025
  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
  • Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston

LEAD PLAINTIFF DEADLINE: SEPTEMBER 12, 2022

CLASS PERIOD: PURSUANT AND/OR TRACEABLE TO MISSFRESH'S JUNE 2021 IPO THROUGH JULY 12, 2022

CONTACT AN ATTORNEY
: (484) 270-1453 or at info@ktmc.com

Kessler Topaz is one of the world's foremost advocates in protecting the public against corporate fraud and other wrongdoing. Our securities fraud litigators are regularly recognized as leaders in the field individually and our firm is both feared and respected among the defense bar and the insurance bar. We are proud to have recovered billions of dollars for our clients and the classes of shareholders we represent.

MISSFRESH'S ALLEGED MISCONDUCT

In June 2021, Missfresh conducted its initial public offering (IPO), selling 21 million American Depository Shares ("ADSs") at $13.00 per ADS.

On April 29, 2022, after trading hours, Missfresh filed a Notification of Late Filing on a Form 12b-25, which announced that Missfresh "will not be able to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021 … by the prescribed filing deadline of April 30, 2022." Missfresh explained that "[t]he independent Audit Committee of [Missfresh]'s board of directors, with the assistance of professional advisors, is in the process of conducting an internal review of certain matters, including those relating to transactions between [Missfresh] and certain third-party enterprises." Following this news, Missfresh ADSs fell 13% to close at $0.448 per ADS on May 2, 2022, the next trading day.

Then, on May 24, 2022, after trading hours, Missfresh issued a press release entitled "Missfresh Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F" announcing "that it received a notification letter dated May 19, 2022 . . . from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq"), indicating that [Missfresh] is not in compliance with the requirements for continued listing." Following this news, Missfresh ADSs fell 9% over the next two trading days to close at $0.167 per ADS on May 26, 2022.

Finally, on July 1, 2022, Missfresh issued a press release entitled "Missfresh Announces the Substantial Completion of the Audit Committee-Led Independent Internal Review." In the press release, Missfresh disclosed that "certain revenue associated with these reporting periods in 2021 may have been inaccurately recorded in [Missfresh]'s financial statements." As of the date the complaint was filed, Missfresh ADSs closed at $0.389 per ADS, well below Missfresh's IPO price of $13.00 per ADS.

WHAT CAN I DO?

Missfresh investors may, no later than September 12, 2022 seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. Kessler Topaz Meltzer & Check, LLP encourages Missfresh investors who have suffered significant losses to contact the firm directly to acquire more information.

More on The PennZone
  • Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
  • ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
  • Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
  • Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
  • Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving

CLICK HERE TO SIGN UP FOR THE CASE

WHO CAN BE A LEAD PLAINTIFF?


A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

Contacts

Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Braces for Teenagers in Allentown Offered by Exeter Smiles
  • Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
  • JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
  • Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
  • Jay Tapp was named Managing Director in British Columbia
  • Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
  • GormanSquared Announces Provisional Patent
  • Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
  • 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
  • NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
  • Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
  • Chewy Chums™ Launches NeverBite™ on Kickstarter
  • DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
  • Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
  • Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
  • Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
  • Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
  • $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
  • Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban

Popular on PennZone

  • Gas Wolf® Officially Becomes a Registered Trademark - 1162
  • 11th annual Florida Blueberry Festival April 26 & 27, 2025 - 168
  • Village Vapes and Cooking 4 Autism Announce Inaugural Partnership at MEGA 420 EVENT - 134
  • Jed the Fish, The Rapscallion of Los Angeles KROQ's Airwaves and Provocateur, Has Signed Off at 69 - 113
  • The Ultimate Med Spa Growth Engine: PatientNow and Aesthetix CRM Announce Strategic Integration
  • The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy
  • Goosechase Rolls Out Unlockable Missions, Its Most Anticipated Feature Yet
  • LIB Large-Scale Walk-In Test Chamber Full Process Delivery: MIL-STD-810H Chambers Enable Extreme Environment Testing
  • PebblePad Welcomes Justin Reilly as New CEO to Drive Innovation and Growth
  • Portland Hosts Mensa's 2025 Mind Games®

Similar on PennZone

  • QVC Honors Elton John with Inaugural Icon Award
  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
  • Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
  • Cybersecurity is Protecting Your Personal Information and Your Portfolio
  • The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
  • $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
  • SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
  • Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
  • Jay Tapp was named Managing Director in British Columbia
  • Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us